Get startedLog in
    Picture of Astellas Pharma logo

    4503 — Astellas Pharma News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareConservativeLarge CapSuper Stock
    All News

    Brief: Astellas Pharma Inc - U.S. FDA Approves Expanded Label For Astellas' Izervay(Avacincaptad Pegol Intravitreal Solution) For Geographic Atrophy

    Picture of Astellas Pharma logoAstellas Pharma
    12/02/2025 23:32
    Feb 13 (Reuters) - Astellas Pharma Inc  4503.T :
    * ASTELLAS PHARMA INC: U.S. FDA APPROVES EXPANDED LABEL FOR ASTELLAS' IZERVAY(AVACINCAPTAD
PEGOL
INTRAVITREAL SOLUTION) FOR GEOGRAPHIC ATROPHY

Source text:  ID:nTSnl8b9b9 
Further company coverage:  4503.T 

 (Reporting by Tokyo Newsroom)
 ((+81345201189;))

    Recent news on Astellas Pharma

    See all news